The toxicity of dysregulated Plk1 activity revealed by its suppressor mutations

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Polo-like kinase 1 (Plk1) is a crucial mitotic kinase regulating cell cycle progression.
• Plk1 activation involves phosphorylation and release from its inhibitory polo-box domain.
• The precise spatiotemporal regulation of Plk1 activity remains incompletely understood.

Purpose of the Study:

• To investigate the mechanisms of Plk1 activation and its spatiotemporal regulation.
• To identify factors influencing Plk1 activity and cellular localization.
• To explore therapeutic interventions targeting Plk1.

Main Methods:

• Expression of constitutively active human Plk1 in bacterial and human cells.
• Identification and structural prediction of Plk1 suppressor mutations.
• Analysis of Plk1 substrate phosphorylation and mitotic progression.
• Assessment of cell proliferation and localization of Plk1 mutants.

Main Results:

• Constitutively active Plk1 expression induced toxicity in bacterial cells, leading to suppressor mutations.
• These mutations were located near the kinase active site, reducing kinase activity.
• Expression of activated Plk1 mutants in human cells caused mitotic defects due to reduced substrate phosphorylation.
• Human cell proliferation was unaffected unless activated Plk1 mutants were mislocalized during mitosis.

Conclusions:

• Bacterial toxicity assays can reveal insights into kinase regulation.
• Spatiotemporal control is essential for Plk1 function in human cells.
• Understanding Plk1 regulation provides a basis for therapeutic strategies.